Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis

Detalhes bibliográficos
Autor(a) principal: Cargnin, Simone Tasca
Data de Publicação: 2019
Outros Autores: Staudt, Andressa Finkler, Menezes, Camila, Azevedo, Ana Paula de, Fialho, Saara Neri, Tasca, Tiana, Teles, Carolina Bioni Garcia, Gnoatto, Simone Baggio
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/181062
Resumo: Trichomonas vaginalis and Leishmania spp. are protozoal species responsible for millions of cases of parasitic diseases worldwide. Considering the potential of natural products and the need for more effective and less toxic alternatives to treat trichomoniasis and leishmaniasis, this study aimed to evaluate the effect of two series of triterpenes derivatives with different modifications at C-3 and C-28 positions of the ursolic acid (UA) and betulinic acid (BA) against trophozoites of Trichomonas vaginalis and promastigotes forms of Leishmania (L.) amazonensis. The compounds modified just at C-3 were the most active. The 3β-acetyl betulinic acid (1b) reduced the trophozoites viability of T. vaginalis at 74%, followed by the 3-oxo ursolic acid and 3-oxo betulinic acid (3a and 3b) compounds (55% of reduction). The compound 3β-isobutyl ursolic acid (7a) inhibited the viability of L. amazonensis promastigotes by 55%. Therefore, analyzing the structure-activity relationship and the data of literature, it is possible to suppose that the inclusion of polar groups in the skeletons could improve the antiprotozoal activity. Overall, further studies are necessary to develop triterpenic derivatives with more powerful trichomonicidal and leishmanicidal properties.
id USP-31_06d78193d8f2806360a2036fc938ba44
oai_identifier_str oai:revistas.usp.br:article/181062
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalisBetulinic acidLeishmania amazonensisSemisynthesisTrichomonas vaginalis.Ursolic acidTrichomonas vaginalis and Leishmania spp. are protozoal species responsible for millions of cases of parasitic diseases worldwide. Considering the potential of natural products and the need for more effective and less toxic alternatives to treat trichomoniasis and leishmaniasis, this study aimed to evaluate the effect of two series of triterpenes derivatives with different modifications at C-3 and C-28 positions of the ursolic acid (UA) and betulinic acid (BA) against trophozoites of Trichomonas vaginalis and promastigotes forms of Leishmania (L.) amazonensis. The compounds modified just at C-3 were the most active. The 3β-acetyl betulinic acid (1b) reduced the trophozoites viability of T. vaginalis at 74%, followed by the 3-oxo ursolic acid and 3-oxo betulinic acid (3a and 3b) compounds (55% of reduction). The compound 3β-isobutyl ursolic acid (7a) inhibited the viability of L. amazonensis promastigotes by 55%. Therefore, analyzing the structure-activity relationship and the data of literature, it is possible to suppose that the inclusion of polar groups in the skeletons could improve the antiprotozoal activity. Overall, further studies are necessary to develop triterpenic derivatives with more powerful trichomonicidal and leishmanicidal properties.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2019-12-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/18106210.1590/s2175-97902019000317481Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17481 Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17481 Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17481 2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/181062/168011Copyright (c) 2019 Brazilian Journal of Pharmaceutical Scienceshttp://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessCargnin, Simone Tasca Staudt, Andressa Finkler Menezes, Camila Azevedo, Ana Paula de Fialho, Saara Neri Tasca, Tiana Teles, Carolina Bioni Garcia Gnoatto, Simone Baggio 2021-01-19T16:47:29Zoai:revistas.usp.br:article/181062Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2021-01-19T16:47:29Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis
title Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis
spellingShingle Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis
Cargnin, Simone Tasca
Betulinic acid
Leishmania amazonensis
Semisynthesis
Trichomonas vaginalis.
Ursolic acid
title_short Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis
title_full Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis
title_fullStr Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis
title_full_unstemmed Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis
title_sort Evaluation of triterpenes derivatives in the viability of Leishmania amazonensis and Trichomonas vaginalis
author Cargnin, Simone Tasca
author_facet Cargnin, Simone Tasca
Staudt, Andressa Finkler
Menezes, Camila
Azevedo, Ana Paula de
Fialho, Saara Neri
Tasca, Tiana
Teles, Carolina Bioni Garcia
Gnoatto, Simone Baggio
author_role author
author2 Staudt, Andressa Finkler
Menezes, Camila
Azevedo, Ana Paula de
Fialho, Saara Neri
Tasca, Tiana
Teles, Carolina Bioni Garcia
Gnoatto, Simone Baggio
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Cargnin, Simone Tasca
Staudt, Andressa Finkler
Menezes, Camila
Azevedo, Ana Paula de
Fialho, Saara Neri
Tasca, Tiana
Teles, Carolina Bioni Garcia
Gnoatto, Simone Baggio
dc.subject.por.fl_str_mv Betulinic acid
Leishmania amazonensis
Semisynthesis
Trichomonas vaginalis.
Ursolic acid
topic Betulinic acid
Leishmania amazonensis
Semisynthesis
Trichomonas vaginalis.
Ursolic acid
description Trichomonas vaginalis and Leishmania spp. are protozoal species responsible for millions of cases of parasitic diseases worldwide. Considering the potential of natural products and the need for more effective and less toxic alternatives to treat trichomoniasis and leishmaniasis, this study aimed to evaluate the effect of two series of triterpenes derivatives with different modifications at C-3 and C-28 positions of the ursolic acid (UA) and betulinic acid (BA) against trophozoites of Trichomonas vaginalis and promastigotes forms of Leishmania (L.) amazonensis. The compounds modified just at C-3 were the most active. The 3β-acetyl betulinic acid (1b) reduced the trophozoites viability of T. vaginalis at 74%, followed by the 3-oxo ursolic acid and 3-oxo betulinic acid (3a and 3b) compounds (55% of reduction). The compound 3β-isobutyl ursolic acid (7a) inhibited the viability of L. amazonensis promastigotes by 55%. Therefore, analyzing the structure-activity relationship and the data of literature, it is possible to suppose that the inclusion of polar groups in the skeletons could improve the antiprotozoal activity. Overall, further studies are necessary to develop triterpenic derivatives with more powerful trichomonicidal and leishmanicidal properties.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-09
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181062
10.1590/s2175-97902019000317481
url https://www.revistas.usp.br/bjps/article/view/181062
identifier_str_mv 10.1590/s2175-97902019000317481
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/181062/168011
dc.rights.driver.fl_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2019 Brazilian Journal of Pharmaceutical Sciences
http://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17481
Brazilian Journal of Pharmaceutical Sciences; v. 55 (2019); e17481
Brazilian Journal of Pharmaceutical Sciences; Vol. 55 (2019); e17481
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222915003678720